Literature DB >> 27115719

Outcomes of follow-up care after an emergency department visit among pediatric asthmatics in the military health system.

Michael Smiley1, Nicholas Sicignano2, Toni Rush2, Rees Lee3, Elizabeth Allen1.   

Abstract

BACKGROUND AND OBJECTIVES: Asthma exacerbations frequently trigger emergency department (ED) visits. Guidelines recommend timely follow-up after an ED visit for asthma, however, other studies have questioned the quality of follow-up care and their effect on subsequent ED utilization. We evaluated follow-up care on asthma outcomes in pediatric asthmatics enrolled in the Military Health System (MHS) after an ED visit for asthma.
METHODS: This retrospective study utilized MHS data to evaluate 2-17-year-old persistent asthmatics with an ED visit for asthma between 2010-2012. Demographics, medication dispensing, and subsequent asthma related ED and hospital utilization were compared between those with or without a 28-day follow-up appointment.
RESULTS: 10,460 of 88,837 persistent asthmatics met inclusion criteria for an asthma ED visit. 4,964 (47.5%) had ≥ 1 follow-up visit. In the 29-365 days after their ED visit, 21.1% of the follow-up cohort required an ED re-visit compared to 24.0% of the patients without follow-up. Follow-up care was associated with a reduction in ED re-visits (adjusted hazard ratio 0.86; 95% confidence interval 0.79, 0.93). Controller medications were dispensed to 76.0% of the follow-up cohort within 90 days of their ED visit compared to 49.7% in the group without follow-up.
CONCLUSIONS: Despite universal access to healthcare, less than half of pediatric MHS asthma patients had follow-up within 28 days of an ED visit. Those with follow-up were more likely to fill a controller medication within 90 days post-ED visit, and less likely to have an asthma ED re-visit in the subsequent year.

Entities:  

Keywords:  Asthma; emergency department; follow-up visits; pediatric

Mesh:

Substances:

Year:  2016        PMID: 27115719     DOI: 10.3109/02770903.2016.1170141

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  5 in total

1.  Association between pediatric asthma care quality and morbidity and English language proficiency in Ohio.

Authors:  Martha P Montgomery; Elizabeth D Allen; Olivia Thomas; Byron F Robinson; Donnie Clark; Ann Connelly; Joshua A Mott; Elizabeth Conrey
Journal:  J Asthma       Date:  2018-06-14       Impact factor: 2.515

2.  Predictors of repeated acute hospital attendance for asthma in children: A systematic review and meta-analysis.

Authors:  Cristina Ardura-Garcia; Marie Stolbrink; Seher Zaidi; Philip J Cooper; John D Blakey
Journal:  Pediatr Pulmonol       Date:  2018-06-05

3.  Predictors of severe asthma attack re-attendance in Ecuadorian children: a cohort study.

Authors:  Cristina Ardura-Garcia; Erick Arias; Paola Hurtado; Laura J Bonnett; Carlos Sandoval; Augusto Maldonado; Lisa J Workman; Thomas A E Platts-Mills; Philip J Cooper; John D Blakey
Journal:  Eur Respir J       Date:  2019-11-14       Impact factor: 16.671

4.  Prospective study of factors associated with asthma attack recurrence (ATTACK) in children from three Ecuadorian cities during COVID-19: a study protocol.

Authors:  Natalia Cristina Romero; Philip Cooper; Diana Morillo; Santiago Mena-Bucheli; Angélica Ochoa; Martha E Chico; Claudia Rodas; Augusto Maldonado; Karen Arteaga; Jessica Alchundia; Karla Solorzano; Alejandro Rodriguez; Camila Figueiredo; Cristina Ardura-Garcia; Max Bachmann; Michael Richard Perkin; Irina Chis Ster; Alvaro Cruz
Journal:  BMJ Open       Date:  2022-06-16       Impact factor: 3.006

5.  Preventing unscheduled hospitalisations from asthma: a retrospective cohort study using routine primary and secondary care data in the UK (The PUSH-Asthma Study)-protocol paper.

Authors:  Nikita Simms-Williams; Prasad Nagakumar; Rasiah Thayakaran; Nicola Adderley; Richard Hotham; Adel Mansur; Krishnarajah Nirantharakumar; Shamil Haroon
Journal:  BMJ Open       Date:  2022-08-19       Impact factor: 3.006

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.